A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
2 other identifiers
interventional
40
1 country
1
Brief Summary
The goal of this study is to determine the extent to which excess dietary simple sugars serve as a secondary mediating factor in Cystic fibrosis-related diabetes (CFRD) development. The main questions it aims to answer are:
- Whether conducting a randomized 2x2 factorial design that evaluates acute postprandial changes in glucose over 2 hours following ingestion of a mixed meal challenge that varies by glycemic index and consumption of a sugar-sweetened beverage is acceptable and feasible.
- What are the preliminary changes in postprandial hyperglycemia, islet cell function, and incretin response to a high or low Glycemic Index mixed meal tolerance test (MMTT) with and without Sugar-Sweetened Beverages (SSB) in adolescents and young adults with CF Participants will be randomized to a mixed diet and blood will be drawn before and after the mixed meal challenge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 22, 2024
CompletedFirst Submitted
Initial submission to the registry
March 28, 2024
CompletedFirst Posted
Study publicly available on registry
April 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedApril 5, 2024
April 1, 2024
1.4 years
March 28, 2024
April 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Recruitment Rate
Recruitment rate of participants. Goal is to recruit 3 participants per month.
2 years
Refusal Rate
Refusal rates for participation. 20%of screened participants will refuse to participate
2 years
Investigator Fidelity
Capacity of the research team to manage the intervention. Goal is \>85%.
2 years
Participant Fidelity
Feasibility of data collection, including primary and secondary outcome measures. Goal is \>85%
2 years
Acceptability
Acceptability and burden of intervention on participants. Likert scale response of \>3(out of 5) on post study evaluation that study is not burdensome and acceptable
2 years
Retention Rates
Retention rates as the participants complete the intervention. Goal is \>80%
2 years
Recruitment
Length of time it takes to recruit enough participants into the study. Goal is to recruit all patients by the end of second quater of the second year.
2 years
Secondary Outcomes (15)
Change in plasma Cysteine (Cys)
Baseline, 2 hours
Change in plasma Cystine (CySS)
Baseline, 2 hours
Change in plasma Glutathione (GSH)
Baseline, 2 hours
Change in plasma Glutathione Disulfide (GSSG)
Baseline, 2 hours
Change in redox potentials (EhCys/ CySS and EhGSH/GSSG)
Baseline, 2 hours
- +10 more secondary outcomes
Study Arms (4)
SSB+ HI- GI
EXPERIMENTALAll standardized mixed meal challenges will be similar in calories (kcal) and percent of calories from carbohydrates (45%), protein (15%), and fat (40%). Each meal will provide 1/3rd of the subject's estimated kcal needs per current CF nutrition guidelines
SSB + LO- GI
EXPERIMENTALAll standardized mixed meal challenges will be similar in calories (kcal) and percent of calories from carbohydrates (45%), protein (15%), and fat (40%). Each meal will provide 1/3rd of the subject's estimated kcal needs per current CF nutrition guidelines
NSSB+ HI- GI
EXPERIMENTALAll standardized mixed meal challenges will be similar in calories (kcal) and percent of calories from carbohydrates (45%), protein (15%), and fat (40%). Each meal will provide 1/3rd of the subject's estimated kcal needs per current CF nutrition guidelines
NSSB+ LO- GI
EXPERIMENTALAll standardized mixed meal challenges will be similar in calories (kcal) and percent of calories from carbohydrates (45%), protein (15%), and fat (40%). Each meal will provide 1/3rd of the subject's estimated kcal needs per current CF nutrition guidelines
Interventions
The following are considered SSBs: non-diet soft drinks/sodas, flavored juice drinks, sweetened tea, energy drinks, and electrolyte replacement drinks.
The Glycemic Index of the high-GI meals will be at least 75
The Glycemic Index of the low- -GI meals will not be higher than 55.
Eligibility Criteria
You may qualify if:
- English speaking
- Diagnosis of CF based on the presence of two known CF causing mutations and/or positive sweat test
- Pancreatic insufficiency
- Baseline dietary consumption of \>10% total kcal from added sugars and self-reported consumption of \>/= sugar-sweetened beverages per week
You may not qualify if:
- Current use or anticipated use of medication that is known to raise or lower blood glucose in the past 4 weeks.
- Oral or IV glucocorticoid current or previous use in the past 4 weeks will prohibit enrollment in the study.
- Recent pulmonary exacerbation within 3 weeks of enrollment and/or an acute illness requiring a change in antibiotics will also exclude participants.
- BMI below the 5th percentile or greater than the 95th percentile for age and sex
- FEV1 \<40% or awaiting a lung transplant;
- Prior lung or liver transplant or kidney or liver dysfunction.
- Diagnosis of CF liver disease.
- Uncontrolled exocrine pancreatic insufficiency/malabsorption
- Diagnosis of CFRD
- G-tube feeds (bolus and/or continuous)
- Current enrollment in another intervention study
- Changes in diet to lose or gain weight
- Gluten allergy or intolerance
- Current pregnancy or lactation or plans to become pregnant during study period
- History of drug or alcohol abuse
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Advanced Pediatrics: Emory Healthcare
Atlanta, Georgia, 30329, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tanicia Daley, MD, MPH
Emory University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 28, 2024
First Posted
April 5, 2024
Study Start
March 22, 2024
Primary Completion
September 1, 2025
Study Completion
September 1, 2025
Last Updated
April 5, 2024
Record last verified: 2024-04